These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12718485)

  • 1. Content and classification of clinical trials at a university hospital in Japan.
    Nakamura T; Yamamoto K; Nagai R; Horiuchi R
    Jpn Heart J; 2003 Mar; 44(2):235-42. PubMed ID: 12718485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
    Russ H; Busta S; Jost B; Bethke TD
    Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nurse awareness of clinical research: a survey in a Japanese University Hospital.
    Yanagawa H; Takai S; Yoshimaru M; Miyamoto T; Katashima R; Kida K
    BMC Med Res Methodol; 2014 Jul; 14():85. PubMed ID: 24989623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan.
    Sato Y; Sakaguchi S; Takechi K; Chuma M; Yagi K; Kane C; Goda M; Hamano H; Aoe Y; Nokihara H; Kubo Y; Hashimoto I; Yanagawa H
    Biol Pharm Bull; 2022; 45(3):374-377. PubMed ID: 35228403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Projects not initiated by investigators: a retrospective analysis of the queries raised by the institutional ethics committees of a teaching hospital.
    Kuyare SS; Marathe PA; Shetty YC; Kamat SK; Katkar JV; Thatte UM
    J Postgrad Med; 2014; 60(1):46-50. PubMed ID: 24625939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doctor-initiated clinical trials and the revised pharmaceutical affairs law].
    Takano T; Saijo N
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1391-7. PubMed ID: 14584270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with GCP in the pharmaceutical industry [corrected].
    Rämsch KD
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent changes in quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Fujimura A
    Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
    Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of NCI-mandated scientific review on protocol development and content.
    Ning N; Yan J; Xie XJ; Gerber DE
    J Natl Compr Canc Netw; 2015 Apr; 13(4):409-16. PubMed ID: 25870377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of quality in Japanese clinical trials.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Need to establish academic research organization for cancer clinical trial and clinical research system having clinical investigators and study coordinators, with special reference to promotion of medical and life science research policy].
    Shimoyama M
    Gan To Kagaku Ryoho; 1999 Jan; 26(2 Suppl):235-46. PubMed ID: 9987525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and institutional review board issues.
    Skolnick BE
    Adv Neurol; 1998; 76():253-62. PubMed ID: 9408484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends and controversies in industry-sponsored clinical trials.
    Reed CR; Camargo CA
    Acad Emerg Med; 1999 Aug; 6(8):833-9. PubMed ID: 10463557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current issues surrounding women and minorities in drug trials.
    Wermeling DP; Selwitz AS
    Ann Pharmacother; 1993; 27(7-8):904-11. PubMed ID: 8364277
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.